- Home
- TRNS vs GOSS Comparison
TRNS vs GOSS Comparison
Compare TRNS & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRNS | GOSS |
|---|---|---|
| Founded | 1964 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.9M | 615.7M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TRNS | GOSS |
|---|---|---|
| Price | $70.95 | $0.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $116.00 | $4.91 |
| AVG Volume (30 Days) | 144.1K | ★ 27.3M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 78.81 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $278,421,000.00 | $114,701,000.00 |
| Revenue This Year | $21.75 | N/A |
| Revenue Next Year | $7.55 | N/A |
| P/E Ratio | $191.53 | ★ N/A |
| Revenue Growth | ★ 7.30 | N/A |
| 52 Week Low | $50.23 | $0.33 |
| 52 Week High | $97.08 | $3.87 |
Technical Indicators
Market Signals| Indicator | TRNS | GOSS |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 23.21 |
| Support Level | $71.05 | $0.33 |
| Resistance Level | $81.17 | $1.23 |
| Average True Range (ATR) | 3.16 | 0.09 |
| MACD | -1.32 | -0.03 |
| Stochastic Oscillator | 25.29 | 10.58 |
Price Performance
Historical ComparisonAbout TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.